Company intelligence / Profile preview

Reveleer

Glendale, California, United States

Ownership: Private
Employees: ~353
Development stage: Other

Overview

Reveleer provides an AI-powered software platform widely adopted by U.S. health plans and risk-bearing providers, consolidating risk adjustment, quality improvement, and clinical intelligence workflows. Its technology enables improved Star Ratings, streamlined coding, and substantial automation in medical record review, used across millions of member records annually. The platform is deployed at scale, processing over 1.1 billion medical chart pages and delivering 2.5 million diagnoses in 2024, but does not perform direct clinical trials or market drugs/devices.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Reveleer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reveleer.

Explore the full profile